Peruvian Hair Loss Treatment

Natural Solution for Hair Loss

Get Instant Access

1. Norwood OT. Male pattern baldness classification and Incidence. South Med J 1975;68:1359-65.

2. Sinclair R. Male pattern androgenetic alopecia. BMJ 1998;317:865-9.

3. Whiting DA. Male pattern hair loss: current understanding. Int J Dermatol 1998;37:561-6.

4. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247-54.

5. Olsen EA. Female pattern hair loss. J Am Acad Dermatol 2001;45:S70-80.

6. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann NY Acad Sci 1951;53:708-28.

7. Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 2001;144:297-304.

8. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999;341:491-7.

9. Bayne EK, Flanagan J, Einstein M et al Immunohistochemical localization of type 1 and 2 5alpha-reductase in human scalp. Br J Dermatol 1999;141:481-91.

10. Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997;109: 296-300.

11. Canfield D. Photographic documentation of hair growth in androgenetic alopecia. Dermatol Clin 1996;14:713-21.

12. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996;35:899-906.

13. Katz HI, Hien NT, Prawer SE, Goldman SJ. Long-term efficacy of topical minoxidil in male pattern baldness. J Am Acad Dermatol 1987; 16:711-18.

14. De Groot A, Nater JP, Herxheimer A. Minoxidil: hope for the bald? Lancet 1987;329:1019-22.

15. Rushton DH, Unger WP, Cotteril PC et al Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness. Clin Exp Dermatol 1989;14:40-6.

16. Savin RC, Atton AV. Minoxidil. Update on its clinical role. Dermatol Clin 1993;11:55-64.

17. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol 1999;41:717-21.

18. Lachgar S, Charveron M, Gall Y, Bonafe JL. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. Br J Dermatol 1998;138:407-11.

19. Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001;107:409-17.

20. Kaufman KD, Olsen EA, Whiting D et al. Finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Am Acad Dermatol 1998;36:578-89.

21. Van Neste D, Fuh V, Sanchez-Pedreno P et al. Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 2000; 143:804-10.

22. Leyden J, Dunlap F, Miller B et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999;40:930-7.

23. The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49.

24. Overstreet JW, Fuh VL, Gould J et al. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 1999;162: 1295-300.

25. Rittmaster RS. Finasteride. N Engl J Med 1994;330:120-5.

26. Drake L, Hordinsky M, Fiedler V et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999;41:550-4.

27. DeVillez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol 1994;130:303-7.

28. Olsen EA. Topical minoxidil in the treatment of androgenetic alopecia in women. Cutis 1991;48:243-8.

29. Orme S, Cullen DR, Messenger AG. Diffuse female hair loss: are androgens necessary? Br J Dermatol 1999; 141: 521-3.

30. Vexiau P, Chaspoux C, Boudou P et al. Effects of minoxidil 2% v. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 2002;146:992-9.

Was this article helpful?

0 0
Hair Loss Prevention

Hair Loss Prevention

The best start to preventing hair loss is understanding the basics of hair what it is, how it grows, what system malfunctions can cause it to stop growing. And this ebook will cover the bases for you. Note that the contents here are not presented from a medical practitioner, and that any and all dietary and medical planning should be made under the guidance of your own medical and health practitioners. This content only presents overviews of hair loss prevention research for educational purposes and does not replace medical advice from a professional physician.

Get My Free Ebook

Post a comment